Hims & Hers Health has decided to cease the sale of its newly launched compounded weight-loss pill shortly after its introduction. This decision follows an announcement by federal regulators who are investigating the company due to the product’s launch. The crackdown aligns with a broader move by regulators to increase scrutiny on compounded medications, especially those for weight loss, now that drug shortages have been resolved. As a result, telehealth companies are navigating shifting regulations, often pivoting to branded alternatives to mitigate such regulatory pressures.
Hims & Hers Health halts compounded weight-loss pill sales following federal probe
